ArticleNature communications2024

Reversible covalent c-Jun N-terminal kinase inhibitors targeting a specific cysteine by precision-guided Michael-acceptor warheads.

Dániel Bálint et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.